Akebia reports Q2 2026 results, VOICE interim data, and new ebribafusp trialAug 5Quarterly updateAkebia Therapeuticsvadadustat
Akebia and USRC halt VOICE trial early after Vafseo beats ESA on safetyJun 30Clinical readoutAkebia Therapeuticsvadadustat
Sign inSign in